Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
26.07.2023 13:12:53

Quest Diagnostics Boosts FY23 Adj. EPS, Revenue Outlook - Update

(RTTNews) - While reporting financial results for the second quarter on Wednesday, Quest Diagnostics Inc. (DGX) raised its adjusted earnings and revenue guidance for the full-year 2023.

For fiscal 2023, the company now projects earnings in a range of $7.52 to $7.92 per share and adjusted earnings in a range of $8.50 to $8.90 per share on net revenues between $9.12 billion and $9.22 billion.

Previously, the company expected earnings in the range of $7.52 to $8.02 per share and adjusted earnings in the range of $8.45 to $8.95 per share on net revenues between $8.93 billion and $9.08 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $8.69 per share on revenues of $9.06 billion for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Analysen zu Quest Diagnostics Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Quest Diagnostics Inc. 157,15 0,80% Quest Diagnostics Inc.